scispace - formally typeset
A

Amy Haskell

Researcher at University of California, San Francisco

Publications -  12
Citations -  4135

Amy Haskell is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Endothelial stem cell & Endothelium. The author has an hindex of 11, co-authored 12 publications receiving 3917 citations.

Papers
More filters
Journal ArticleDOI

Abnormalities in Pericytes on Blood Vessels and Endothelial Sprouts in Tumors

TL;DR: It is concluded that pericytes are present on most tumor vessels but have multiple abnormalities, including altered expression of marker proteins, which raises the possibility of an involvement in sprout growth or retraction in tumors.
Journal ArticleDOI

Inhibition of Vascular Endothelial Growth Factor (VEGF) Signaling in Cancer Causes Loss of Endothelial Fenestrations, Regression of Tumor Vessels, and Appearance of Basement Membrane Ghosts

TL;DR: Treatment with VEGF signaling inhibitors caused robust and early changes in endothelial cells, pericytes, and basement membrane of vessels in spontaneous islet-cell tumors of RIP-Tag2 transgenic mice and in subcutaneously implanted Lewis lung carcinomas.
Journal ArticleDOI

Abnormalities of basement membrane on blood vessels and endothelial sprouts in tumors.

TL;DR: The findings indicate that basement membrane covers most tumor vessels but has profound structural abnormalities, consistent with the dynamic nature of endothelial cells and pericytes in tumors.
Journal ArticleDOI

Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice.

TL;DR: It is indicated that angiogenic endothelial cells in these models avidly bind and internalize cationic liposomes and liposome-DNA complexes but not other types ofliposomes, which raises the possibility of using cationsome- DNA complexes to target diagnostic or therapeutic agents selectively toAngiogenic blood vessels in tumors and sites of chronic inflammation.